Two researchers affiliated with UW School of Medicine were named to TIME's 100 most influential people for 2022.
The finding supports theory that genetic differences between individuals and species can affect the acquisition of mutations.
An analysis suggests that other criteria have a more ethical basis to help decide which patients to prioritize for lifesaving care.
Before 2021, the survival rate of extreme preemies was poor. An initiative at UW Medicine changed that.
Creating a novel population of mutant tissues helps scientists deduce the cause of polycystic kidney disease and other cilia-linked illnesses.
A Phase 3 clinical trial found that the second-generation vaccine generates high levels of neutralizing antibodies.
If medication supplies dwindle, hospitals worldwide should prioritize health equity and people at greatest risk, a new paper argues.
Project aims to create a genome reference that represents the genetic diversity of all the populations on Earth.
A trial will test three evidence-based counseling therapies to see if one, or more than one in combination, results in better outcomes.
If resource shortages became dire, triage team members would have to deprioritize some patients from getting life-sustaining care.